Emily Leven
Icahn School of Medicine at Mount Sinai
16 Papers
101 Citations
Emily Leven is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 10 publications. Previous affiliations of Emily Leven include Mount Sinai Hospital.
Chat about Author
Papers
Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study.
Ania Wajnberg,Mayce Mansour,Emily Leven,Nicole M. Bouvier,Gopi Patel,Adolfo Firpo-Betancourt,Rao Mendu,Jeffrey S. Jhang,Suzanne Arinsburg,Melissa R. Gitman,Jane Houldsworth,Emilia Mia Sordillo,Alberto Paniz-Mondolfi,Ian Baine,Viviana Simon,Judith A. Aberg,Florian Krammer,David Reich,Carlos Cordon-Cardo +18 more
- 25 Sep 2020
TL;DR: Analysis of a large cohort of convalescent serum donors in the New York City region suggests that most patients with mild COVID-19 seroconvert 4 weeks after illness, and raises questions about the use of PCR to clear positive individuals.
172
Hyper IgM Syndrome: a Report from the USIDNET Registry
Emily Leven,Patrick Maffucci,Hans D. Ochs,Paul Scholl,Rebecca H. Buckley,Ramsay Fuleihan,Raif S. Geha,Coleen K. Cunningham,Francisco A. Bonilla,Mary Ellen Conley,Ronald M. Ferdman,Vivian Hernandez-Trujillo,Jennifer M. Puck,Kathleen E. Sullivan,Elizabeth Secord,Manish Ramesh,Charlotte Cunningham-Rundles +16 more
TL;DR: Analysis of the USIDNET Registry provides data on the common clinical features of this rare syndrome, and in contrast with previously published data, demonstrates longer survival times and reduced gastrointestinal manifestations.
Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.
TL;DR: Immunologic testing of HCW in the Mount Sinai Health System found the prevalence of SARS-CoV-2 IgG in this population was high, and based on patterns seen in other viral illnesses, it is possible IgG presence may protect against reinfection.
Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City
TL;DR: HCW with SARS-CoV-2 IgG may become their safest frontline providers as the authors learn if their IgG antibodies confer immunity, and knowing IgG antibody status may ease concerns regarding personal risk as this pandemic continues.
35
Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19.
Alon Yehuda Mazori,Ilana Bass,Lili Chan,Kusum S. Mathews,Deena R. Altman,Aparna Saha,Howard Soh,Huei Hsun Wen,Sonali Bose,Emily Leven,Jing Gennie Wang,Gohar Mosoyan,Pattharawin Pattharanitima,Giampaolo Greco,Emily J. Gallagher +14 more
TL;DR: In this paper, the authors explore the relationship between hyperglycemia in the presence and absence of diabetes mellitus and adverse outcomes in critically ill patients with coronavirus disease 2019 (COVID-19).
33